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Background:Medication dispensing errors are common in clinical trials, and have a signiﬁcant impact on
the quality and validity of a trial. Therefore, the deﬁnition, calculation and evaluation of such errors are
important for supporting a trial’s conclusions. A variety of medication dispensing errors can occur. In this
paper, we focus on errors in trials where the intervention includes multiple therapies that must be given
in a pre-speciﬁed order that varies across treatment arms and varies in duration.
Methods: The Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial was a Phase III
multi-site, randomized trial to compare the effectiveness and safety of 1:1:1 transfusion ratios of plasma
and platelets to red blood cells with a 1:1:2 ratio. In this trial, these three types of blood products were to
be transfused in a pre-deﬁned order that differed by treatment arm. In this paper, we present approaches
from the PROPPR trial that we used to deﬁne and calculate the occurrence of out of order blood
transfusion errors. We applied the proposed method to calculate protocol adherence to the speciﬁed
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Fig. 1. Blood transfusion order in the Protocol of the
Note: The left side is for the 1:1:1 group. The right sid
represents one unit.
2132 H. Zhu et al. / Injury, Int. J. Care Injured 47 (2016) 2131–2137Results: Using our proposedmethod, protocol adherence was greater in the 1:1:1 group than in the 1:1:2
group (96% vs 93%) (p<0.0001), although out of order transfusion errors in both groups were low. Final
transfusion ratios of plasma to platelets to red blood cells for the 1:1:1 ratio groupwas 0.93:1.32:1, while
the transfusion ratio for the 1:1:2 ratio group was 0.48:0.48:1.
Conclusions:Overall, PROPPR adherence to blood transfusion order pre-speciﬁed in the protocolwas high,
and the required order of transfusions for the 1:1:2 group was more difﬁcult to achieve. The approaches
proposed in this manuscript were useful in evaluating the PROPPR adherence and are potentially useful
for other trials where a speciﬁc treatment orders with varying durations must be maintained.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Medication dispensing errors, generally deﬁned as a deviation
from the medication order as written in the protocol, are not
uncommon in clinical trials. For example, the ARISTOTLE trial
successfully proved the efﬁcacy of apixaban in the reduction in
stroke, major bleeding and death [1]. However, the approval of
apixaban was delayed because of the reported medication
dispensing errors including giving the wrong drug. In trials, it is
important to evaluate the extent of adherence to the protocol in
terms of medication dispensing. The most common medication
dispensing errors reported in the literature are wrong drugs,
strength, form or quantity, as well as wrong labels [2]. Examples
and detailed discussion about these issues can be found in the
literature [3,4].
In this paper, we studied a special case ofmedication dispensing
errors illustrated using the Pragmatic, Randomized Optimal
Platelet and Plasma Ratios (PROPPR) trial, i.e. deviation of the
order of transfusion of blood products from the order speciﬁed in
the protocol [5,6].We propose a fundamental rationale and speciﬁc
approaches to deﬁne and count the blood transfusion errors. We
applied our approach to data from the PROPPR trial, and carried out
a comprehensive evaluation to compute adherence to the order of
treatment as speciﬁed in the protocol. The approaches we
developed for quantifying adherence to blood product order can
be applied to other clinical trials where order of interventions is
complex and may vary over time.PROPPR trial.
e is for the 1:1:2 group. One doseMaterials and methods
The PROPPR trial was a Phase III multi-site, randomized trial
to compare the effectiveness and safety of a 1:1:1 transfusion
ratio of plasma to platelets to red blood cells (RBCs) with a 1:1:2
ratio, where the 1:1:1 (1:1:2) ratio means that for each
transfused unit of plasma, another one unit of platelets and
one (two) units of RBCs are also transfused to the patient.
According to the protocol, these three types of blood products
were to be transfused to patients in a pre-speciﬁed order as
shown in Fig. 1. Each dose of platelets in the ﬁgure represents a
pool of 6 units on average. The blood products were delivered in
containers which differed according to treatment assignment.
Every container for the 1:1:1 group was the same, while two
different containers were delivered sequentially to the patient in
the 1:1:2 group. How the units of plasma were made rapidly
available has been discussed [7], and other trial details can be
found in previous publications [5,6].
The order of blood products transfused during the PROPPR
protocol was decided by multiple factors. For example, Platelets
could not be placed on ice in the container with the other blood
units, so one dose of platelets was placed into a separate opaque
package attached to the outside of the transport container. In order
to conceal the contents of the study containers until after patients
were randomized and enrolled and promote blinding, a “sham”
platelet bag was attached to the odd numbered container in the
1:1:2 treatment group.of platelets represents a pool of six units and one dose of red blood cells or plasma
H. Zhu et al. / Injury, Int. J. Care Injured 47 (2016) 2131–2137 2133Identiﬁcation of out of order treatments
In this paper, protocol adherence was measured by one minus
the patient’s average blood transfusion error proportion, and each
patient’s blood transfusion error proportion was calculated by
dividing the total number of wrongly transfused blood products by
the total number of transfused blood products. The fundamental
rationale behind the deﬁnition of protocol adherence included the
following considerations. First, the total number of errors was
counted based on the number of blood product units given in the
wrong sequence. Because we were measuring adherence to the
protocol in terms of the order of the blood products transfused, and
not assessing the effect of adherence on treatment outcome, weTable 1
Error Criteria for the 1:1:1 group.
Condition (1–9 for single unit, 10–15 for tie)
1. First unit transfused from a container is NOT platelet, and there are no other plate
transfused from that container.
2. First unit transfused from a container is NOT platelet, and there exists other plate
transfused from the container.
3. First unit transfused from a container is platelet, and next unit is NOT RBC
4. First unit transfused froma container is platelet, and there exists other units of platele
from the same container
5. RBC transfused which is followed by plasma
6. Plasma transfused which is followed by RBC
7. RBC transfused followed by RBC
8. Plasma transfused followed by plasma
9. Either RBC or plasma is transfused followed by a wrong unit of platelet.
10. The tie is not at the beginning of a container, and there are no platelets in the tie
11. The tie is not at the beginning of a container, there is at least one platelet in the tie,
has been transfused from the container.
12. The tie is not at the beginning of a container, there is at least one platelet in the tie,
has NOT been transfused from the container
13. The ﬁrst transfusions from the container are a tie, and there are no platelets in t
14. The ﬁrst transfusions from the container are a tie, there is at least one platelet in
15. Either RBC or plasma is transfused, followed by a tie.
Table 2
Error Criteria for the 1:1:2 group.
2a: Error Criteria for odd numbered container in the 1:1:2 group
Condition (1–6 for single unit, 7–8 for tie)
1. First unit transfused from a container is NOT RBC
2. The second unit transfused from a container is NOT RBC
3. The unit transfused following 2 or more RBCs is NOT plasma
4. The unit transfused following plasma is NOT RBC
5. Platelets were transfused from a container
6. Either RBC or plasma were transfused following a wrong unit of platelet
7. Any ‘tied’ transfusions from a container
8. Either RBC or plasma trasnfusion is followed by a tie.
2b: Error Criteria for even numbered container in the 1:1:2 group
Condition (1–7 for single unit, 8–13 for tie)
1. First unit transfused from a container is NOT platelets
2. First unit transfused from a container is NOT platelets, and other platelet units wer
from the container
3. First unit transfused from a container is platelets, but the next unit is NOT RBC
4. First unit transfused froma container is platelets, and other units of plateletwere tran
the same container
5. The unit transfused following 2 or more RBCs is NOT plasma
6. The unit transfused following plasma is not RBC
7. Either RBC or plasma were transfused following a wrong unit of platelet
8. The tie is not at the beginning of a container, and there are no platelets in the tie.
9. The tie is not at the beginning of a container, there is at least one platelet in the tie, and
been transfused in the container.
10. The tie is not at the beginning of a container, there is at least one platelet in the tie,
has NOT been transfused in the container
11. The ﬁrst units transfused from the container are a tie, and there are no platelets
12. The ﬁrst units transfused from the container are a tie, there is at least one platel
13. Either RBC or plasma was transfused, followed by a tie.did not assign weights to different types of errors. Second, the
intention was to only penalize an error once. Instead of counting
every deviation from the correct order as an error, we determined
what speciﬁc approaches had been used to ﬁx an error and only
penalized for the original error rather than the ﬁx. Third, our goal
was to be consistent across different cases and avoid ad hoc
approaches that might not be relevant to other projects. Lastly, in
this trial the transfusion protocol could be stopped in themiddle of
a container due to death or hemorrhage control, but the error rate
prior to stopping was of interest. The speciﬁc methods of deﬁning
and calculating blood product transfusion errors are listed in
Tables 1 and 2. Next, we will explain these rules which can be
generalized to other situations.Error
let units +1
let units +(number of units of platelet-1)
+1
t transfused +number of excess units of platelets
+0
+0
+1
+1
+0
. +Etie1
and platelet +Etie1
and platelet +Etie2
he tie. +Etie1
the tie. Assume the ﬁrst platelet has been given correctly, and the error
for the rest are calculated based on rule 11 or rule 12.
+0
Error
+1
+1
+1
+1
+number of units of platelet
+0
+Etie1
+0
Error
+1
e transfused +(number of units of platelet-1)
+1
sfused from +number of excess units of platelets
+1
+1
+0
+Etie1
platelet has +Etie1
and platelet +Etie2
in the tie. +Etie1
et in the tie. Assume the ﬁrst platelet has been given correctly, and the error
for the rest are calculated based on rule 11 or rule 12.
+0
2134 H. Zhu et al. / Injury, Int. J. Care Injured 47 (2016) 2131–2137The ﬁrst challenge was how to deﬁne an error. One possibility
was to compare the transfused blood products with the required
order in the protocol one by one (unit-based approach). However, if
plasmawas the ﬁrst transfused blood product of the ﬁrst container
in the 1:1:1 group instead of platelets, a nurse could ﬁx the error in
at least two ways. The nurse might follow the protocol from the
second unit by transfusing RBCs and continuing in compliance
with the protocol until the end of this container. The unit-based
error-counting method deﬁned previously works well in this case
and returns one error. Alternately, a nurse might ﬁx this error by
immediately transfusing a platelet unit and then follow the
protocol as if starting a new container. In this case, the unit-based
strategy of deﬁning errors would return 13 errors. Therefore, the
unit-based error calculation approach is not a consistent strategy
acrossmultiple situations, sowe considered an alternate approach.
As in Fig.1, the overall pattern of transfusion for the 1:1:1 group
was alternating units of RBCs and plasma interspersed with
platelets. For this reason, we can consider a pattern-based
approach to error counting within each study container: the ﬁrst
unit was a platelet, every RBC should be followed by plasma, and
every plasma unit should be followed by a RBC except for the
thirteenth unit (plasma) in the container. For example, if two
successive RBCs were given after the initial platelet to a patient in
the 1:1:1 group, one error would be counted for the second RBC if
the next unit transfused was plasma, and that plasma would be
correct, since it followed an RBC. Similarly, the pattern of
transfusions from odd-numbered containers for the 1:1:2 group
was that every two RBCs should be followed by a plasma unit and
every plasma unit should be followed by an RBC. Therefore, any
RBC after one or more plasmas was correct, and any plasma after
two or more RBCs was correct. For example, if the order of
transfusion for the ﬁrst three units in an odd numbered container
for the 1:1:2 group was plasma, plasma, RBC, the RBC was deemed
to be correct, even if the third unit in the protocol should be
plasma. For all transfusions fromeven numbered containers for the
1:1:2 group, the pattern was to ﬁrst transfuse a unit of platelets,
then follow every two RBC units with plasma, and every plasma
unit transfused should be followed by an RBC. The rationality of the
above idea can be intuitively explained by similar activity in real
life such as amarching forward of a soldier. The correct order is left
leg followed by right leg and right leg followed by left leg. If a
soldier took two successive left leg steps, the next correct one is
always a right leg step. This idea has been proved to be consistently
feasible for all situations in this project, and should work for other
projects with similar problems, and complies with the third
rationale mentioned above.
The second major difﬁculty was how to deal with potential
errors involving platelets. Ignoring platelets, RBCs and plasma
were supposed to be transfused in a consistent pattern depending
on treatment group. An out of order platelet can affect counting
errors for this platelet as well as other blood products transfused
after it. There were three general cases of out-of-order platelets in
the 1:1:1 group and in the even-numbered container of the 1:1:2
group, both of which should have a platelet at the ﬁrst position: (1)
No platelets were transfused from the container at all; (2) The ﬁrst
unit transfused from the container was not platelet, but one or
more doses of platelets were reported in another position; (3) The
ﬁrst unit transfused from a container was platelets, but additional
doses of platelets were transfused from the same container. For
case (1), the ﬁrst position was counted as an error. We counted
errors for case (2) based on the second rationale of the project and
only penalized for the original error and not the ﬁxing of the error.
According to the protocol, there should be one platelet in the
container. If the ﬁrst onewas not platelet, the nursemight try to ﬁx
the original error by transfusing one platelet in the middle of this
container in order to attain the appropriate ratio. Therefore, thisincorrectly positioned platelet used to ﬁx the original error should
not be penalized. But additional doses of platelets after the ﬁrst
transfused were counted as errors. In Case (3), all the excess units
of platelets should be counted as errors. Finally, in the odd
numbered container in the 1:1:2 group which did not contain any
platelets based on the protocol, all platelets transfused were
counted as errors.
The third major difﬁculty followed from the latter error, i.e.,
how to deﬁne errors for the blood units transfused after an out of
order platelet. This was the most complicated situation and no
strategywas perfect for this case. Note that the out of order platelet
has already been counted as an error (for example, rule 1 and 2 in
Table 1). So we proposed that both RBC and plasma, which
followed a wrong unit of platelet, could be deemed to be correct.
Using the 1:1:1 group as an example, the following cases might
occur: (i) RBC-platelet-plasma, (ii) RBC-platelet-RBC, (iii) plasma-
platelet-plasma, (iv) plasma-platelet-RBC. A plasma should follow
a RBC and a RBC should follow a plasma based on the protocol.
Since we have counted the platelet as an error, the nurse might
want to follow the protocol ignoring the wrong platelet in order
not to produce more errors. As a result, both case (i) and (iv) were
acceptable under the pattern-based approach. For case (ii), the
nurse might be trying to follow the protocol by giving an RBC after
the platelet, whichwas replacing a plasma unit. In this situation, all
following units could be delivered following the original protocol
and might be the nurse’s way of minimizing the number of errors.
Another reasonable explanation for case (ii) was that, if the
protocolwas followed, the next unit after a plateletwould be a unit
of RBCs. Similar arguments can be given for case (iii) and for the
1:1:2 group.
Other complications in measuring protocol adherence arose
because some sites administered multiple units of blood products
simultaneously, through either a rapid infuser or more than one
patient blood vessel. Our analysis treated these multiple simulta-
neous transfusions as “tie” scenarios. In PROPPR, the exact time of
transfusion of blood productswas recorded. First, therewas no real
order in a tie, but we could assign the ties a sequence in order to
compare them with the protocol. The problem was that many
sequences were possible. Consistent with rationale 2, we assigned
the order leading to the fewest blood transfusion errors. Second,
‘tie' scenarios varied according to the number of units in the tie and
the beginning position. For example, if the tie was from the second
unit transfused from a container for the 1:1:1 group and contained
four units, the correct orderwas RBC, plasma, RBC, plasma. If the tie
started from the third unit and contained three units, the correct
order was plasma, RBC, plasma. In a small dataset, it might be
possible to assign an order to the ties manually, but our goal was
creating a consistent computerized algorithm that works univer-
sally for all cases.
Starting with the simplest case where only units of RBC and
plasma comprised the ‘tied’ positions in the 1:1:1 group, we
compared the number of units of RBC and plasma reported with
the corresponding numbers based on the protocol. Regardless of
the correct order in the protocol, the number of units that can be
matched between the reported data and the protocol (i.e. the
maximum number of units without an error) was the minimum of
the actual number of RBCs in the tie and number of RBCs in the
protocol plus the minimum of actual number of plasma in the tie
and number of plasma in the protocol for the tie positions. As a
result, the number of errors for the tie was as follows:
Etie1 =Ntie-min (Rtie, RProtocol)-min (Ptie, PProtocol)
whereNtiewas the total number of units in the tie, Rtie and Ptiewere
the actual number of RBC and plasma in the tie respectively, and
RProtocol and PProtocol were the number of RBC and plasma in the
protocol for the tie positions respectively. This formula worked for
Table 3
Number and proportion of the transfused blood products by treatment arm.
Blood products 1:1:1 group
(n= 336)
Na (%b)
1:1:2 group
(n = 333)
Na (%b)
1. Platelets 655(10.2%) 293(5.2%)
2. Red Blood Cells 2981(46.5%) 3648(64.3%)
3. Plasma 2781(43.3%) 1733(30.5%)
a N is the number of doses of corresponding transfused blood products, where
one dose of platelets represents a pool of six units and one dose of red blood cells or
plasma represents one unit.
b Column percentage represents the proportion of corresponding transfused
blood products within each treatment arm.
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container, and there were no platelets involved in the tie; (2) The
tie was not at the beginning of a container, there was at least one
platelet involved in the tie, and another dose of platelets has been
transfused from the same container. In this case, all the platelets
involved in the tie were errors, so the above formula still worked;
(3) The tiewas at the beginning of the container, and therewere no
platelets involved in the tie. In this case, other than the matched
RBCs and plasma, all the other units were errors. In summary, for
all three cases, we only need to match RBCs and plasma between
the data and the protocol, and all unmatched unitswere errors. The
above formula can be applied in other projects where ties are
possible.
In this project, therewere twomore complicated cases. The ﬁrst
case was if the tie was not at the beginning of a container from the
1:1:1 group, there was at least one dose of platelets in the tie, and
no other platelets were given in the container, then the number of
errors for this tie was
Etie2 =Ntie-min (Rtie, RProtocol)-min (Ptie, PProtocol)-1,
since this platelet in the tie can be thought of as a correct substitute
of the missing one at the ﬁrst position. If the tie was at the
beginning of a container for the 1:1:1 group and there was at least
one platelet in the tie, we could manually assign one of the
platelets to the ﬁrst position, and calculated the number of errors
for the remaining units based on rule 10 or rule 11 in Table 1. The
guidelines for dealing with ties in the 1:1:2 group (Table 2) was
similar to what we have introduced for the 1:1:1 group.
Analysis of error rates
Analysis of errors focused on the unique patient level. We
deﬁned error proportion to be the proportion of errors in blood
product transfusion for each patient, where the denominator was
the total number of blood products for each patient. Note that the
blood product transfusion errors could be affected by numerous
factors that changed over time such as availability of trained
personnel. For this reason, the nonparametric approach, Wilcoxon
rank sum test, was used to test the hypothesis that the two
treatment groups differed in transfusion error proportions,
assuming that the treatment effects and error severity do not
vary over time.
Results
There were 19659 transfused blood products for 680 patients in
the data collected, among which 12091 unique RBCs, plasma, and
platelets units were transfused during the randomized phase and
were included in this study. There were 7568 observations
representing other types of blood products (n = 268), missing data
(n = 10) or from prior to or after the randomized period (n = 7290),
which were excluded from this analysis. As a result, 11 patients
without any remaining transfused blood products were removed,
among whom 2 are from the 1:1:1 group and 9 are from the 1:1:2
group. Finally, the analysis included 669 unique patients, 336
patients (6417 observations) in the 1:1:1 group and 333 patients
(5674 observations) in the 1:1:2 group.
Table 3 describes the proportion of the transfused blood
products by treatments. In the 1:1:1 group, 2781 units of plasma,
655 doses of platelets, and 2981 units of RBCs were transfused. In
the 1:1:2 group, 1733 units of plasma, 293 doses of platelets, and
3648 units of RBCs were transfused. Note that one dose of platelets
in the table represented a pool of 6 units of platelets on average.
Therefore, overall average transfusion ratios of plasma and
platelets to RBCs for the 1:1:1 group were 0.93:1.32:1, while thecorresponding transfusion ratios for the 1:1:2 group were
0.48:0.48:1. Looking at the ratios transfused in the trial, adherence
to the protocol was high. Note that the transfusion protocol could
be stopped in the middle of a container due to death or
hemorrhage control or other reasons, and the 6 units of platelets
were always given at the beginning of a container, which explained
why the platelets were higher than expected in the 1:1:1 group.
The mean error proportion in the 1:1:1 group was 0.04 with
standard deviation 0.11, while the mean error proportion in the
1:1:2 group was 0.07 with standard deviation 0.11. The median
error proportions for both treatment arms were 0, which meant
that more than half of the patients did not have any wrong
transfused blood products. Actually, 248 patients out of 669 had
wrong blood transfusion, among whom 99 patents were from the
1:1:1 group and 149 patients were from the 1:1:2 group. From the
p-value of less than 0.0001, we concluded that the two treatment
groups differed signiﬁcantly in blood product transfusion errors.
Fig. 2 is a box plot showing the distribution of error proportion by
treatment. The 1:1:2 group showed a higher error proportion than
the 1:1:1 group.
In addition to the overall error proportion, we made further
studies on the PROPPR trial and detected other important patterns.
First, the relationship between the error proportion and total
number of transfused blood products were investigated through
Spearman's rank correlation coefﬁcient (Fig. 3). There was a
statistically signiﬁcant positive correlationwith a p-value less than
0.0001. But the positive correlation was weak, and the correlation
was not apparent from the ﬁgure. Second, about half of the patients
(n =334) stopped in the ﬁrst cooler, among whom 183 patients
were from the 1:1:1 group and 151 patients were from the 1:1:2
group. The mean error proportion for these patients in the 1:1:1
group was 0.04 with standard deviation 0.14, while the mean error
proportion for these patients in the 1:1:2 group was 0.06 with
standard deviation 0.12, which was quite consistent with the
whole cohort. Third, we explored the error proportion for patients
who died. Themean error proportion for these patients in the 1:1:1
group was 0.08 with standard deviation 0.19, while the mean error
proportion for these patients in the 1:1:2 group was 0.09 with
standard deviation 0.11. Fourth, we further explored the error
proportion for patients who died before the PROPPR protocol was
discontinued, amongwhom 22 patients were from the 1:1:1 group
and 37 patients were from the 1:1:2 group. The mean error
proportion for these patients in the 1:1:1 group was 0.10 with
standard deviation 0.15, while the mean error proportion for these
patients in the 1:1:2 group was 0.11 with standard deviation 0.14.
Discussion
Medicine dispensing errors are very common in clinical trials.
Typically, these trials focus on simple treatment arms delivering
only one type of medicinewith a ﬁxed dose. In these types of trials,
themost common errors are either wrongmedicine or wrong dose
[(Fig._3)TD$FIG]
Fig. 3. Relationship between error proportion and total number of transfused blood products.
[(Fig._2)TD$FIG]
Fig. 2. Box plot of error proportion by treatment.
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complicated treatment regime, where multiple blood products
were given to patients in a pre-speciﬁed order. In this paper, we
proposed a series of methods to deﬁne and calculate different
types of blood transfusion errors that would be generalizable to
other studies using ordered intervention regimes. These
approaches are potentially useful for future trials with multiple
interventions and order issues in each treatment armwhere it is of
interest to calculate overall adherence.
This paper focused on the adherence to the protocol in terms of
the order of the blood products transfused, and it wasmeasured by
the error proportion. We did not assess the effect of adherence on
treatment outcome with respect to different types of errors.
However, we did do a sensitivity analysis excluding patients who
experienced blood transfusion error, and obtained results similarto the main analysis [5]. Also treatment during the trial was quite
complicated and evaluating the change of error proportion over
time would be difﬁcult. Future research could be carried out to
study the pattern of error proportions as the protocol continues.
It is beyond the scope of this article to identify approaches to
reducing errors. The approaches would generally be study speciﬁc.
For example, in interpreting the observed results of this analysis,
Level 1 trauma centers require the presence of a specialist trauma
surgeon at the bedside. The presence of such a specialist could have
reduced the percentage of errors observed in this analysis.
Additionally, in this study, all transfusions for each patient were
reviewed for gross errors as the study progressed and feedbackwas
provided to the sites in order to prevent similar future errors. This
two could have reduced the percent of errors observed. However,
the focus of this paper was not approaches to reducing errors but
H. Zhu et al. / Injury, Int. J. Care Injured 47 (2016) 2131–2137 2137rather to describe an approach to the calculation of these errors for
a complex treatment regimen. As it stands our method addresses
the adherence question of interest, i.e, can we deﬁne each
participant as an adherent or non-adherent.
Finally, some of the approaches to deﬁning and calculating
errors were speciﬁc to this trial, and served only as a model to
consider for other complex studies of adherence. But it is worth
noting that the proposed fundamental rationale andmajor speciﬁc
approaches generalizable to other trials with similar situations.
By giving trials a tool to assess errors, study speciﬁc approaches can
be put into place to reduce errors, study speciﬁc corrective actions
can be taken, and progress in the reduction of errors can be
monitored.
Conclusions
Overall, PROPPR adherence to blood transfusion order pre-
speciﬁed in the protocol was high, and the required order of
transfusions for the 1:1:2 group was more difﬁcult to achieve. The
approaches proposed in this manuscript were useful in evaluating
the PROPPR adherence and are potentially useful for other trials
where a speciﬁc treatment orders with varying durations must be
maintained.
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